Today I’m speaking with Brad Burge, the Strategic Communications Director of MAPS, the Multidisciplinary Association of Psychedelic Studies.
The nonprofit MAPS was founded in 1986 to bring life enhancing psychedelics through the regulatory system to legitimize their use as prescription medicine.
On the podcast, Brad and I talk about harm reduction, his own experiences with entheogens and festivals, and the state of psychedelic research in 2018. Our conversation includes patenting psilocybin, the promises and pitfalls of Ketamine treatment for depression, MDMA and therapy for PTSD, and ayahuasca and cultural appropriation.
Life is a Festival, so let’s keep experimenting and do so wisely.